Global Pneumothorax Treatment Devices Market Analysis for 2026–2030 with Strategic Forecast Insights for Businesses
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Valuation Is Forecasted For The Pneumothorax Treatment Devices Market By 2030 Starting From Its 2026 Size?
The pneumothorax treatment devices market has experienced significant growth in recent times. This market is projected to expand from $3.98 billion in 2025 to $4.39 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 10.3%. Factors contributing to its historical growth include an increase in traumatic chest injuries, more road accident cases, improvements in hospital emergency infrastructure, the adoption of chest tube procedures, and the expansion of critical care units.
The pneumothorax treatment devices market is anticipated to undergo significant expansion over the next few years. It will grow to $6.43 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. This projected growth can be attributed to several factors such as the rise in portable emergency devices, advancements in thoracic vent systems, increased intensive care unit admissions, the necessity for more rapid lung re-expansion, and the broadening reach of emergency medical services. Prominent trends expected during this forecast period include the swift decompression of lungs in emergencies, the development of portable devices for pneumothorax management, the adoption of minimally invasive chest drainage, enhancements in air leak control systems, and the simplification of bedside treatment kits.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20929&type=smp
Which Market Drivers Are Supporting The Expansion Of The Pneumothorax Treatment Devices Market?
The growing prevalence of respiratory ailments is projected to boost the pneumothorax treatment devices market. Respiratory diseases are health conditions that affect the lungs and airways, thereby impairing breathing and the exchange of oxygen. Increases in respiratory diseases can be linked to factors such as air pollution, smoking, viral infections, and heightened exposure to allergens. Pneumothorax treatment devices find application in these conditions to manage collapsed lungs and restore normal respiratory function. For instance, in September 2025, according to the Australian Bureau of Statistics, an Australia-based government agency, deaths involving influenza increased from 611 deaths in 2023 to 806 deaths in 2024 and further to 1,057 deaths in the year to August 2025, representing a 73% increase from 2023 to the comparable August 2025 period. Deaths involving respiratory syncytial virus (RSV) rose from 380 deaths in 2023 to 468 deaths in 2024 and 399 deaths in the year to August 2025. Therefore, the increasing number of respiratory diseases drives the growth of the pneumothorax treatment devices market.
Which Segment Categories Define The Pneumothorax Treatment Devices Market?
The pneumothorax treatment devices market covered in this report is segmented –
1) By Type: Ventilator Devices, Thoracic Vent Devices, Other Types
2) By Application: Traumatic Pneumothorax, Spontaneous Pneumothorax, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Ventilator Devices: Portable Ventilators, Non-Invasive Ventilators, Invasive Ventilators
2) By Thoracic Vent Devices: Chest Drainage Systems, Heimlich Valves, One-Way Chest Valve Systems
3) By Other Types: Needle Aspiration Devices, Pleural Catheters, Oxygen Therapy Devices
What Major Market Trends Are Driving Changes In The Pneumothorax Treatment Devices Market?
Major companies active in the pneumothorax treatment devices market are prioritizing the development of technologically advanced offerings, like chest X-ray solutions, to maintain their competitive edge. Chest X-ray solutions refer to various imaging systems, equipment, and associated technologies designed to capture detailed radiographic images of the chest area, encompassing the lungs, heart, ribs, and surrounding anatomical structures. As an illustration, in September 2023, Qure.ai, a US-based health tech enterprise, announced that it secured 510(k) FDA clearance for its novel chest X-ray solution, qXR-PTX-PE. This particular solution is crafted to assist in the prompt detection of pneumothorax (PTX) and pleural effusion (PE). The AI-powered software enhances patient care pathways in intensive care units (ICUs) and emergency rooms (ERs) by providing timely notifications to healthcare providers. The qXR-PTX-PE solution analyzes chest X-ray images for crucial findings, significantly boosting triage efficiency in emergency situations, where these conditions pose substantial risks to patient health.
Who Are The Top Companies Competing In The Pneumothorax Treatment Devices Market?
Major companies operating in the pneumothorax treatment devices market are Cardinal Health Inc., Medtronic PLC, Siemens Healthineers AG, Medline Industries Inc., Fujifilm Holdings Corporation, Becton Dickinson and Company (BD), GE HealthCare Technologies Inc., Stryker Corporation, Boston Scientific Corporation, Draegerwerk AG & Co. KGaA, Cook Medical Inc., B. Braun Melsungen AG, Utah Medical Products Inc., Rocket Medical plc, Nobelpharma Co. Ltd., Sinapi Biomedical Inc., UreSil Inc., ATMOS MedizinTechnik GmbH & Co. KG, Betaglue Technologies S.p.A., Selio Medical Inc.
Read the full pneumothorax treatment devices market report here:
How Is The Pneumothorax Treatment Devices Market Distributed Across Key Geographic Regions?
North America was the largest region in the pneumothorax treatment devices market in 2025. The regions covered in the pneumothorax treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Pneumothorax Treatment Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20929&type=smp
Browse Through More Reports Similar to the Global Pneumothorax Treatment Devices Market 2026, By The Business Research Company
Pneumococcal Vaccine Market Report 2026
https://www.thebusinessresearchcompany.com/report/pneumococcal-vaccine-global-market-report
Respiratory Devices And Equipment Therapeutic Market Report 2026
Respiratory Devices And Equipment Therapeutic And Diagnostic Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
